DRUG
Bright Minds·NASDAQ
--
--(--)
--
--(--)
DRUG fundamentals
Bright Minds (DRUG) released its earnings on Aug 11, 2025: revenue was 0 (YoY --), met estimates; EPS was -0.2918 (YoY --), beat estimates.
Revenue / YoY
0
--
EPS / YoY
-0.2918
--
Report date
Aug 11, 2025
EPS
Actual | -1.5185 | -0.8541 | -0.1256 | 0.0069 | -0.2918 | |||||||
Forecast | -0.4434 | -0.0156 | -0.3013 | |||||||||
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | +71.67% | +144.23% | +3.15% |
Revenue
Actual | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0 | 0 | 0 |
Forecast | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0 | 0 |
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Earnings Call
You can ask Aime
What were the key takeaways from Bright Minds’s earnings call?What does Bright Minds do and what are its main business segments?What were the key takeaways from Bright Minds's earnings call?What guidance did Bright Minds's management provide for the next earnings period?Did Bright Minds beat or miss consensus estimates last quarter?What factors drove the changes in Bright Minds's revenue and profit?What is Bright Minds's latest dividend and current dividend yield?What is Bright Minds's gross profit margin?
